Skip to main content

Table 1 General characteristics of study groups

From: Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients

Characteristic/Variable

Non-T2D group (n = 15)

T2D group (n = 10)

p-value

Gender

60% (female)/40% (male)

60% (female)/40% (male)

1.00

Age (year)

54.7 ± 10.0 [49.2 - 60.3]

54.9 ± 8.7 [48.7 - 61.1]

0.89

Hemoglobin (g/dL)

13.6 ± 1.1 [13.0 - 14.3]

13.6 ± 1.4 [12.6 - 14.6]

0.97

Hematocrit (%)

41.1 ± 2.7 [39.6 - 42.7]

40.4 ± 4.0 [37.5 - 43.3]

0.56

Body mass index (kg/m2) *

26.6 ± 3.7 [24.5 - 28.7]

33,7 ± 4,0 [30.8 - 36.6]

0.00

Fasting glucose (mg/dL) *

92.9 ± 9.2 [87.9 -98.0]

167.8 ± 64.0 [117.8 - 258.2]

0.00

HbA1c (%) *

5.8 ± 0.3 [5.6 - 6.0]

9.3 ± 2.1 [7.7 - 10.8]

0.00

Serum adiponectin (ng/mL) *

10911.5 ± 5554.0

[7835.7 - 13987.2]

6729.7 ± 3381.5

[4310.8 - 9148.7]

0.04

Serum urea (mg/dL)

34.2 ± 12.8 [27.1 - 41.3]

38.0 ± 7.8 [32.4 - 43.6]

0.46

Serum creatinine (mg/dL)

0.9 ± 0.2 [0.8 - 1.0]

0,9 ± 0.1 [0.7 - 1.0]

0.93

Total cholesterol (mg/dL)

193.7 ± 48.8 [166.7 - 220.8]

193.5 ± 33.2 [169.8 - 217.2]

0.36

LDL-cholesterol (mg/dL)

119.4 ± 47.0 [93.4 - 145.4]

104.3 ± 31.1 [82.0 - 126.6]

0.84

HDL-cholesterol (mg/dL)

50.8 ± 17.0 [41.4 - 60.2]

42.9 ± 11.0 [35.0 - 50.8]

0.21

Serum triglycerides (mg/dL) *

108.6 ± 48.7 [81.6 -135.6]

254.8 ± 226.4 [92.9 - 416.7]

0.04

Uric Acid (mg/dL)

5.3 ± 1.1 [4.7 - 6.0]

5.7 ± 1.2 [4.8 - 6.5]

0.60

Na (mEq/L)

140.1 ± 2.2 [138.9 - 141.3]

138.8 ± 2.0 [137.3 - 140.3]

0.17

K (mEq/L)

4.3 ± 0.5 [4.0 -4.6]

4.2 ± 0.4 [3.8 - 4.5]

0.49

UACR (mg/g)

11.3 ± 13.2 [4.0 - 18.7]

138.2 ± 229.8 [-26.2 - 302.6]

0.17

Office SBP (mmHg)

154.3 ± 21.6 [142.3 -166.2]

156.5 ± 30.6 [134.7 - 178.4]

0.93

Office DBP (mmHg)

92.9 ± 10.8 [86.9 - 98.8]

90.1 ± 18.2 [77.0 - 103.1]

0.33

  1. The values are expressed as means ± standard deviation; [95% confidence interval]; (*) Statistical significance (p < 0.05); Non-T2D: non type 2 diabetes resistant hypertension; T2D: type 2 diabetes resistant hypertension.